Novo Nordisk Inc. 2026-01-07 Health serious FDA
Health · FDA · Recall #FDA-D-0244-2026
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured… Recall
Issued January 7, 2026 · Novo Nordisk Inc.
In January 2026, Novo Nordisk Inc. recalled the Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Particulate Matter: Hair was found in a prefilled syringe
What you should do
- 1 Stop using Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Novo Nordisk Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Novo Nordisk Inc.
- Category
- Health
- Recall date
- January 7, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the United States.
- Recall number
- FDA-D-0244-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Novo Nordisk Inc. has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.